Search results for "ffpe challenges"

The immunoassay suite from Abcam utilizes recombinant antibodies for greater consistency, sensitivity, and specificity

Learn about Thermo Fisher Scientific’s modular, fit-for-purpose platforms designed specifically to meet the requirements of cell therapy manufacturing right now, and in the future.

Gain insights on topics from CRISPR and gene editing to biomarkers, liquid chromatography advancements and high-sensitivity POC cardiac troponin

Marco Zhong, Director of the National Reference Laboratory for Food Contact Material, discusses ‘forever chemicals’ and why effective FCM testing is more important than ever

Guest editor Dr. Klaus Lindpaintner discusses how innovations in glycoprotein characterization are advancing protein biology and medicine

This on-demand webinar shows how cutting-edge liquid handling, automation, and detection technologies can increase speed and efficiency in your lab

The Twist Alliance CNTG Exome - 41 MB provides highly uniform coverage of the entire exome as well as full coverage of the mitochondrial genome.

As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies

Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice

A complete targeted resequencing solution for a wide range of applications, with fast integrated workflow and options for custom and fixed enrichment panels.

Customizable Targeting of Key Oncology Variants  

Sequence key genes implicated in Lynch Syndrome

Interrogate NSCLC and SCLC genes

Expansive profiling of BRCA1, BRCA2 and PALB2 genes

GEM-X Flex Gene Expression with Feature Barcode technology Single cell RNA sequencing is increasingly being used to profile larger numbers of patient cohorts or different perturbations, making an efficient and scalable workflow paramount.

Orion Biomarkers  are tailored to enable spatial biomarker analysis with maximum flexibility. Choose from a range of labeled antibodies to generate Orion spatial biology data for multiplexed tissue imaging or create new reagents with easy-to-use conjugation kits.

The custom monoclonal antibody reveals potential HER2+ breast cancer target